Oncology & Cancer

Wave of interest in new cancer therapy

Using viruses and bacteria that normally cause disease to cure disease is an apparent contradiction, but it’s fundamental to the work being carried out by Dr. David Ackerley.

Immunology

Immune cell 'survival' gene key to better myeloma treatments

Scientists have identified the gene essential for survival of antibody-producing cells, a finding that could lead to better treatments for diseases where these cells are out of control, such as myeloma and chronic immune ...

Oncology & Cancer

Toward a more efficient therapy for a specific form of leukemia

Chronic myeloid leukemia (CML) is a particular form of leukemia or cancer of the bone marrow, which can be treated with targeted imatinib. However, in some cases this medicine has no effect. Researchers at the VIB Vesalius ...

Immunology

Study casts light on deadly immune response

(Medical Xpress)—Examining a case study of near-death experiences for six healthy men who volunteered to test an experimental drug in London has yielded important insights into potentially deadly over-reactions of the human ...

Immunology

A worm's-eye view of immunity

In 1998, scientists published the first complete genome of a multicellular organism—the worm Caenorhabditis elegans. At the same time, new technologies were emerging to help researchers manipulate genes and learn more about ...

Immunology

Dermatitis could be suppressed as it develops

Excessive immune reactions against the body's own skin cells can lead to painful and even chronic dermatitis. An international team of researchers at the MedUni Vienna, the MedUni Graz and the Salk Institute in California, ...

Diseases, Conditions, Syndromes

The end of the antibiotic era

Doctors' propensity to prescribe antibiotics for any illness and the human behavioural influence on outbreaks have come under the spotlight at the 10th Prestigious Lecture entitled Superbugs: Are the bugs winning the war?

page 2 from 3